Form 4: Brown-Forman Executive Granted Stock Appreciation Rights

Brown-Forman's EVP, General Counsel, and Secretary, Michael E. Carr Jr., was granted 31,463 Stock Appreciation Rights with an exercise price of $31.15, exercisable from May 1, 2028.

Summary

• Michael E. Carr Jr., EVP, General Counsel, and Secretary of Brown-Forman Corp. (BFA, BFB), acquired 31,463 Stock Appreciation Rights (SARs).
• The SARs have an exercise price of $31.15.
• These SARs become exercisable on May 1, 2028, and will expire on April 30, 2035.
• The transaction occurred on July 24, 2025, and was reported on July 25, 2025.
• The acquisition was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged transaction.

Sentiment

Score: 7

Explanation: The grant of Stock Appreciation Rights to a senior executive is a positive signal for management retention and aligns executive incentives with long-term shareholder value creation. It is a standard compensation practice.

Positives

• The grant of Stock Appreciation Rights to a key executive aligns management incentives with long-term shareholder value.
• The use of a Rule 10b5-1(c) plan indicates a structured and pre-planned compensation transaction.

Negatives

• No immediate cash inflow for the executive from this grant, as SARs are exercised in the future.
• The value of the SARs is dependent on the future appreciation of Brown-Forman's Class B Common stock above the exercise price of $31.15.

Risks

• The value of the Stock Appreciation Rights is subject to the future performance and market price of Brown-Forman's Class B Common stock.
• If the stock price does not appreciate above the exercise price of $31.15 by the expiration date, the SARs may expire worthless.

Future Outlook

This filing primarily reports a compensation event and does not contain forward-looking statements about company performance or guidance. The future value of the Stock Appreciation Rights depends on the company's stock performance.

Industry Context

This is a standard executive compensation disclosure. Stock Appreciation Rights are a common form of equity compensation used across various industries to incentivize executives by linking their compensation to stock price performance without requiring them to purchase shares. Brown-Forman, as a consumer staples company (alcoholic beverages), uses such mechanisms to retain talent and align interests, similar to other large, publicly traded companies.

Comparison to Industry Standards

• The grant of Stock Appreciation Rights (SARs) is a common practice in executive compensation across industries, including the consumer staples sector, comparable to companies like Constellation Brands (STZ), Diageo (DEO), or Anheuser-Busch InBev (BUD).
• SARs are often used as an alternative to stock options, providing similar upside potential based on stock price appreciation but without the need for the executive to pay an exercise price, making them more capital-efficient for the executive.
• The specific exercise price of $31.15 would be compared to Brown-Forman's stock price at the time of the grant to assess if it was 'at-the-money' or 'out-of-the-money,' which is standard practice.
• The vesting schedule (exercisable from 05/01/2028) and expiration date (04/30/2035) are typical long-term incentive structures designed to retain executives over several years.

Corporate Governance

Related Party Transactions

• Grant of Stock Appreciation Rights to Michael E. Carr Jr., an executive of Brown-Forman Corp., as part of his compensation package.

Stakeholder Impact

• Shareholders: Potential positive impact if the SARs incentivize the executive to drive stock price appreciation. Dilution risk is minimal as SARs are typically cash-settled or net-settled, but they represent a future compensation expense.
• Management: Strengthens retention and aligns interests with company performance.

Next Steps

• The executive will hold the Stock Appreciation Rights until they become exercisable on May 1, 2028.
• The executive may choose to exercise the SARs at any point between the exercisable date and the expiration date (April 30, 2035), depending on the stock price performance.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (grant of Stock Appreciation Rights) and does not contain information that would fundamentally alter the investment thesis for Brown-Forman. It indicates standard corporate governance and incentive alignment but provides no new operational or financial performance data to warrant a change in investment recommendation.

Keywords

Brown-Forman, BFA, BFB, Stock Appreciation Rights, SARs, Executive Compensation, Insider Transaction, Form 4, Equity Grant, Corporate Governance, Rule 10b5-1